missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Toralizumab Chimeric Recombinant Rabbit Monoclonal Antibody (IDEC-131 (Toralizumab))

Rabbit Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA548310
This item is not returnable.
View return policy
Description
Specificity: This antibody is a non agonistic antibody specifc for human CD40 ligand.
Toralizumab works by binding to interferon gamma, which prevents it from interacting with its receptors on immune cells. This blocks the downstream signaling pathways that lead to inflammation and tissue damage in autoimmune diseases. By blocking interferon gamma, toralizumab aims to reduce inflammation and prevent further tissue damage in affected individuals.
Specifications
| Toralizumab Chimeric | |
| Recombinant Monoclonal | |
| 1 mg/mL | |
| PBS with 0.02% ProClin 300 | |
| P08729 | |
| Rabbit | |
| Protein A | |
| RUO | |
| 3855 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Inhibition Assays, Immunocytochemistry | |
| IDEC-131 (Toralizumab) | |
| Unconjugated | |
| KRT7 | |
| IDEC 131 | |
| The original monoclonal antibody was generated by immunization with a soluble fusion protein of human gp39 (gp39-CD8). | |
| 200 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction